Hub Biomedical Forms as European Commercialization Partner for Musculoskeletal Technologies

March 25, 2014, London, United Kingdom – Hub Biomedical Limited announced today that it has officially opened its doors for business. Based in the United Kingdom, the organization was formed by orthopaedic industry veterans Rick Leach and Andy Caudell. Hub Biomedical aims to provide expert strategic guidance and tactical support to orthopaedic, spine and orthobiologic companies seeking to launch their products or build their brand within the European Union.

The European Union encompasses twenty-eight member states and constitutes a population of over 500 million inhabitants. After the United States, it is the second largest market in the world for medical devices. The top five medical device markets within the European Union are Germany, the United Kingdom, France, Italy and Spain.

Andy Caudell, co-founder, stated “With a combined orthopaedic industry tenure exceeding fifty years, Rick and I saw the need for an agile organization that can deliver crucial in-market advice and support to companies taking their first steps into the attractive European markets. Hub Biomedical intends to offer more than the typical consultancy driven market analysis and strategic recommendations. We will take our strategic insights to the tactical level by partnering with our client’s to execute highly effective local sales, marketing and communication activities that accelerate their European roll-out in a well-planned, efficient and sustainable manner.”

“Hub Biomedical possesses an enviable pan-European network of local independent sales organizations, scientific experts and clinical key opinion leaders” added Rick Leach, co-founder. “We are looking forward to utilizing these connections on behalf of our clients to successfully introduce innovative musculoskeletal repair technologies to the European markets.”

Source: Hub Biomedical Limited

About Hub Biomedical Limited: